Genomic alteration analysis in ovarian cancers
Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
PROVIDER: GSE132088 | GEO | 2020/06/01
REPOSITORIES: GEO
Similar Datasets
Project description:RiboTag mice B6N.129-Rpl22tm1.1Psam/J (# 011029, Jackson Laboratories), which carry a conditional Rpl22 allele (Sanz et al., 2009; doi: 10.1073/pnas.0907143106),were crossed with Pdgfb-iCreER mice that are tamoxifen-inducible form of Cre recombinase in vascular endothelial cells (Claxton et al., 2008; doi: 10.1002/dvg.20367),to generate Ribotag-Pdgf-β1 Cre mice
2023-09-20 | GSE223714 | GEO
Project description:Transcriptional profiling of mouse whole liver comparing control WT B6 mice with B6 growth hormone-deficient little, B6 androgen receptor-null Tfm mice, and STAT5b KOs normalized to WT on B6 and BALB/c backgrounds. All animals were 10-week-old males initiated with DEN. Oberley et al. Molecular carcinogenesis 2014 May 17. doi: 10.1002/mc.22165.
2014-08-09 | GSE60253 | GEO
Project description:The dataset contains 72 RNA-seq samples obtained from adult (P150) C57BL/6JCrl mice. Samples are from total heart, liver and kidney tissue. Four different genotypes are included in the data: 1) wild type, 2) transgenic Ciona intestinalis AOX in Rosa26 locus (Szibor et al. 2017, DOI: 10.1242/dmm.027839), 3) respiratory chain complex III deficient Bcs1lp.S78G knock-in mice (a GRACILE syndrome patient mutation, Leveen et al. 2011, DOI: 10.1002/hep.24031) and 4) a cross between the AOX transgenic and Bcs1lp.S78G mice (Rajendran et al. EMBO Mol Med. In press).
2018-11-16 | E-MTAB-7416 | biostudies-arrayexpress
Project description:Female H9 ESCs were maintained on matrigel and differentiated into hepatocyte like cells as previously described (Szkolnicka D, Farnworth SL, Lucendo-Villarin B, Hay DC. Curr Protoc Stem Cell Biol. 2014 Aug 1;30:1G.5.1-12. doi: 10.1002/9780470151808.sc01g05s30) . Sodium L-Lactate (L7022, Sigma, Gillingham, UK) 10mM, Sodium Pyruvate 1mM (Sigma, Dorset, UK) and Octanoic Acid (C2875, Sigma, Gillingham, UK) 2mM for 48 hours before harvesting.
2018-01-30 | E-MTAB-6227 | biostudies-arrayexpress
Project description:Transcriptional profiling of mouse whole liver comparing control WT B6 mice with B6 growth hormone-deficient little, B6 androgen receptor-null Tfm mice, and STAT5b KOs normalized to WT on B6 and BALB/c backgrounds. All animals were 10-week-old males initiated with DEN. Oberley et al. Molecular carcinogenesis 2014 May 17. doi: 10.1002/mc.22165. Three-condition experiment, WT vs. little and Tfm livers. Biological replicates: 3 control replicates, 3 mutant replicates. Little and Tfm normalized to WTa, B6 STAT5b KO
2014-08-09 | E-GEOD-60253 | biostudies-arrayexpress
Project description:Choline (reference 1) and glucose (reference 2) was studied using HR MAS MR spectroscopy data and 105 and 38 gene transcripts were selected respectively from the microarray data to study differences between two xenograft models. Reference 1: Moestue SA et al, Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models, BMC Cancer 2010 Aug 17;10:433 (PMID: 20716336). Reference 2: Grinde et al., NMR Biomed. 2011 Dec;24(10):1243-52. doi: 10.1002/nbm.1683. (PMID: 21462378)
2010-12-08 | GSE25915 | GEO
Project description:This experiment follows, extends and validates our previous findings published in Leukemia & Lymphoma as original article entitled \Molecular heterogeneity and centrosome-associated genes in multiple myeloma\. [Kryukov F, Nemec P, et al, Leuk Lymphoma. 2013 Sep;54(9):1982-8. Doi: 10.3109/10428194.2013.764416] (ArrayExpress Accession E-MTAB-1038). This experiment submission is enriched by supplemental R-script-based data file named \for_external_validation.RData\ which includes script for CAGP model application.
2016-05-01 | E-MTAB-4032 | biostudies-arrayexpress
Project description:We quantified the protein abundances of Mycoplasma pneumoniae (Mpn), a genome-reduced organism, by combining selected reaction monitoring of a reduced set of labeled peptides and label-free shotgun mass spectrometry. A set of 77 labeled peptides were synthesized and used as internal standard peptides to precisely and quantitatively measure the absolute concentrations of proteins in a tandem mass spectrometer [1]. The heavy peptides were chosen based on tryptic peptides of endogenous proteins previously observed in mass spectrometry experiments and that covered more than a 1000-fold range of protein concentrations. Three time points of Mpn growth curve (48, 72 and 96 hours) and the heavy peptides were injected per triplicates in order to calculate the endogenous amount of each peptide (single reference point quantitation) [2], resulting in the absolute quantification of 73 reference proteins. A calibration curve between the absolute amount of reference proteins and the proteome-wide protein intensities allowed the estimation of absolute protein abundances for all detected proteins [3]. In order to further improve the quantification, four additional label-free mass spectrometry datasets of Mpn [4] using different protein extraction methods, from a previous project, were combined with the original dataset, which allowed to quantify the abundances of 528 proteins (75% of the proteome of Mpn). 1. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A. 2003;100: 6940–6945. doi:10.1073/pnas.0832254100 2. Campbell J, Rezai T, Prakash A, Krastins B, Dayon L, Ward M, et al. Evaluation of absolute peptide quantitation strategies using selected reaction monitoring. Proteomics. 2011;11: 1148–1152. doi:10.1002/pmic.201000511 3. Schmidt A, Kochanowski K, Vedelaar S, Ahrné E, Volkmer B, Callipo L, et al. The quantitative and condition-dependent Escherichia coli proteome. Nat Biotechnol. 2016;34: 104–110. doi:10.1038/nbt.3418 4. Miravet-Verde S, Ferrar T, Espadas-García G, Mazzolini R, Gharrab A, Sabido E, et al. Unraveling the hidden universe of small proteins in bacterial genomes. Mol Syst Biol. 2019;15: e8290. doi:10.15252/msb.20188290 5. Yus E, Maier T, Michalodimitrakis K, van Noort V, Yamada T, Chen W-H, et al. Impact of genome reduction on bacterial metabolism and its regulation. Science. 2009;326: 1263–1268. doi:10.1126/science.1177263 6. Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6: 359–362. doi:10.1038/nmeth.1322 7. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell. 2009;138: 795–806. doi:10.1016/j.cell.2009.05.051 8. Martens L, Van Damme P, Van Damme J, Staes A, Timmerman E, Ghesquière B, et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics. 2005;5: 3193–3204. doi:10.1002/pmic.200401142 9. Desiere F, Deutsch EW, King NL, Nesvizhskii AI, Mallick P, Eng J, et al. The peptideatlas project. Nucleic Acids Res. 2006;34: D655–D658. Available: https://academic.oup.com/nar/article-abstract/34/suppl_1/D655/1132687 10. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4: 222. doi:10.1038/msb.2008.61 11. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26: 966–968. doi:10.1093/bioinformatics/btq054 12. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20: 3551–3567. doi:10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 13. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4: 207–214. doi:10.1038/nmeth1019
2023-08-31 | PXD035159 | Pride
Project description:The main goal of the present work was to use an in vitro adipogenic-differentiation mode, with mesenchymal stem-cells (MSC) from human bone-marrow, to study whole-transcriptomic differential gene-expression when such cells are induced to differentiate into adipocytes in absence or presence of oleuropein. See details below. This work is complementary to a previously published one (Casado-Daz et al, 2016): Casado-DÃaz, A., Anter, J., Müller, S., Winter, P., Quesada-Gómez, J. M. and Dorado, G. (2016): Transcriptomic analyses of adipocyte differentiation from human mesenchymal stromal-cells (MSC). Journal of Cellular Physiology 9999: 1-14. DOI: 10.1002/jcp.25472. It corresponds to EMBL-EBI ArrayExpress accession E-MTAB-4884.
2018-12-31 | E-MTAB-5211 | biostudies-arrayexpress
Project description:Colorectal laterally spreading tumors (LSTs) are rare comparing to adenomas but are becoming more prevalent. Unlike many neoplasms in colons, LST grows to extremely large size, usually greater than 10mm in diameter while rarely invades deeply. Also, there is a low tendency for LSTs to become cancerous. The epigenetic landscape of LST has not been defined. In this study, we used a genome-wide methylation profiling technology, i.e. the Illumina Human Methylation 450K array, to query the main epigenetic difference between LST and para-cancerous samples. Our results suggest that LST displays significant decrease in DNA methylation, especially in some intergenic regions (IGR). By integration of public data for adenomas and colorectal cancers, we defined the commonality and specific epigenetic signatures for these three types of neoplasms in colon, in particular LST and adenomas which represent precancerous conditions. These three diseases shared little specific DNA methylation abnormalities. However, our pathway-level analysis revealed that certain pathways were common targets of epimutation. More interestingly, different diseases seem to employ distinct epigenetic insult to disturb these pathways. Between LST and adenoma, we found eight pathways were commonly targeted but the epi-mutation patterns were opposite between the two diseases. Comparison between precancerous conditions and invasive states revealed the key pathways governing the progression to malignancy, including CAMs and PI3K-Akt pathways.
2019-01-01 | GSE106556 | GEO